Fig. 4From: A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP familyImmune signature in two groups. A, B discrepancy analysis of tumor-infiltrating immune cells between two groups in the (A) TCGA and (B) GSE14520 cohortsBack to article page